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ABSTRACT: Acyclovir (ACV) has been commonly used as an antiviral for decades. Although
the crystal structure of the commercial form, a 3:2 ACV/water solvate, has been known since
1980s, investigation into the structure of anhydrous ACV has been limited. Here, we report
the characterization of four anhydrous forms of ACV and a new hydrate in addition to the
known hydrate. Two of the anhydrous forms appear as small needles and are stable to air
exposure, whereas the third form is morphologically similar but quickly absorbs water from the
atmosphere and converts back to the commercial form. The high-temperature modification is
achieved by heating anhydrous form I above 180◦C. The crystal structures of anhydrous form I
and a novel hydrate are reported for the first time. © 2010 Wiley-Liss, Inc. and the American
Pharmacists Association J Pharm Sci 100:949–963, 2011
Keywords: polymorphism; hydrates; X-ray diffractometry; Raman spectroscopy; crystal
structure; calorimetry (DSC); solid-state NMR spectroscopy; FTIR spectroscopy
INTRODUCTION
Solid form diversity in organic compounds is a
widespread phenomenon that encompasses crystal
polymorphism, solvates, and cocrystals; in the case
of active pharmaceutical ingredients, the different
physical properties that forms display can influence
properties including bioavailability and morphology,
among others.1 Conformational flexibility and hydro-
gen bonding are considered factors that influence
the ability of a molecule to form polymorphs,2 but
these are not the only contributing factors and, in
some cases, are completely absent. Polymorphism
is traditionally investigated through the use of dif-
ferent solvents and temperatures of crystallization,
whereas newer methods for the discovery and control
of solid forms include polymer-induced heteronucle-
ation (PIHn).3,4 Here, the crystallization of acyclovir
(ACV, Fig. 1) is reported using PIHn and traditional
solid form discovery techniques. The ability of ACV to
exist in multiple hydrogen bonding networks and its
flexible side chain are important factors to be consid-
ered when investigating the existence of and charac-
terizing the multiple solid forms of this drug. Crys-
tal forms were characterized by Raman spectroscopy,
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powder X-ray diffraction (PXRD), single crystal X-ray
diffraction, differential scanning calorimetry (DSC),
Fourier transform infrared (FTIR) spectroscopy, solid-
state nuclear magnetic resonance (SS-NMR) spec-
troscopy, and thermogravimetric analysis (TGA).
Acyclovir is a guanine derivative possessing an-
tiviral activity and commonly used in the treatment
of herpes. Previous studies have yielded the crystal
structure of the commercial form, a 3:2 ACV/water
hydrate.5,6 This hydrate crystallizes in the mono-
clinic space group P21/n with cell parameters of a =
25.459(1) Å, b = 11.282(1) Å, c = 10.768(1) Å, and
β = 95.16(1)◦ (Fig. 2).6 A previous study by Kristl et
al.7 proposed the existence of two stable anhydrous
forms and an unstable form but provided character-
ization limited to thermal analysis and dissolution
rates of the forms. Recently, Sohn and Kim8 showed
the existence of two anhydrous polymorphs in ad-
dition to the known hydrate and an acetic acid sol-
vate through PXRD, thermal analysis, and dissolu-
tion rates. The packing arrangement of the anhydrous
form versus that of the commercial hydrate remains
unknown and is of particular interest due to previ-
ous findings that the hydrate has a faster dissolution
rate than the anhydrous form7; this observation con-
trasts with the trend typically observed in the liter-
ature where anhydrous forms dissolve more quickly
than the hydrate.7,9 Here, we demonstrate that ACV
displays, at minimum, two anhydrous forms stable
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Figure 1. Molecular structure of acyclovir (also known
as 2-amino-9-((2-hydroxyethoxy)methyl)-1H-purin-6(9H)-
one).
under ambient conditions, two forms that do not ex-
ist under ambient conditions, and two hydrates. In
addition, structure determination by single crystal
X-ray diffraction was carried out to better understand
the molecular packing arrangements and properties
of each form of ACV.
Experimental
Materials
Commercial ACV (Spectrum, Gardena, California)
was used as supplied. Solvents, purchased from
Fisher Scientific (Fairlawn, New Jersey), were used
directly.
Preparation of Polymorphs and Hydrates
Form I of ACV was obtained by heating a sample of
commercial ACV at a rate of 5◦C/min to 180◦C on a
hotstage and then allowing the sample to cool. Single
crystals of form I were obtained during polymorph
screening using polymeric heteronuclei by crystalliz-
ing from a methanol solution in the presence of Nylon
6. Form II was obtained by heating 20.0 mg of com-
mercial ACV in 20 mL of methanol to 68◦C in a closed
vessel until complete dissolution was achieved and
then allowing the solution to evaporate quickly while
heat was still being applied. Single crystals of form
II were obtained from evaporating a methanol solu-
tion of ACV in the presence of Nylon 6/12. Form III
is a metastable form that is obtained by heating com-
mercial ACV (denoted here as form V) on a hotstage
to a temperature between 130◦C and 150◦C. Form IV
is a high-temperature modified form that is formed
by heating form I above 180◦C. Form VI, a 1:2 ACV/
H2O hydrate, was found during a polymorph screen-
ing using polymeric heteronuclei and was found to
crystallize in the presence of poly(ethylene terephtha-
late), poly(vinyl chloride), poly(vinyl stearate), and
polypropylene. Nylon 6/12 yielded a mixture of forms
II and VI. Single crystals of appropriate size and qual-
ity of form VI were obtained on a terpolymer derived
from 29% (ethoxyethyl)methacrylate, 38% methyl-
methacrylate, and 33% divinyl benzene. Form V, the
commercial 3:2 ACV/H2O hydrate, was used as sup-
plied.
Raman Spectroscopy
Raman spectra were recorded on a Renishaw inVia
Ramanmicroscope equipped with a 20× objective and
utilizing a 633-nm laser. The scan range was 100 to
3600 cm−1, using three scans of 30-s length each per
spectrum. Samples were analyzed on an aluminum
foil holder and a silicon standard was used to cali-
brate the instrument. Variable temperature Raman
spectroscopy was performed using a Linkam LTS 350
hotstage equipped with a TMS 94 controller. Samples
were analyzed using a 647-nm laser over a scan range
of 100 to 3600 cm−1. The heating rate was controlled
using Renishaw Wire 2.0 software.
Infrared Spectroscopy
Fourier transform infrared spectroscopy analyses
were performed on forms I, II, and V using an attenu-
ated total reflectance accessory (ATR; ThermoNicolet
Avatar model 360-FTIR). The scan range was 700 to
3800 cm−1, employing 1024 scans with a resolution of
1 cm−1. Samples were analyzed on the ATR stage and
the empty stage was used as the background.
X-ray Diffraction
Powder X-ray diffraction patterns were obtained on
a Rigaku R-Axis Spider diffractometer at 50 kV
and 40 mA, using monochromated Cu K" radiation
(1.5406 Å). Samples were packed in a glass capil-
lary and run at room temperature. Images were inte-
grated from 2.5◦ to 50◦ 2θ using the AreaMax2 soft-
ware package and the resulting pattern was analyzed
using MDI Jade 8. Variable temperature PXRD was
performed by heating the sample in a glass capillary
at 1◦C/min, using an Oxford Cryostream Plus instru-
ment. The unit cell constants of form II were deter-
mined on this instrument at 90 K by indexing several
crystals in single crystal mode; however, none of these
were judged suitable for structure determination.
Crystal structures were obtained on a Bruker
SMART CCD-based X-ray diffractometer equipped
with an LT-2 low-temperature device and normal fo-
cus Mo-target X-ray tube (8 = 0.71073) operated at
2000-W power (50 kV, 40 mA). The X-ray intensities
were measured at 85 (2) K; the detector was placed
at a distance 4.980 cm from the crystal. Analysis of
the data showed negligible decay during the data col-
lection; the data were processed with SADABS and
corrected for absorption. Structures were solved and
refinedwith the Bruker SHELXTL (version 6.12) soft-
ware package. All nonhydrogen atoms were refined
anisotropically, with the hydrogen atoms placed in
idealized positions.
Thermomicroscopy
A Mettler Toledo FP82HT hotstage with a FP 90 con-
trol processor was used for thermomicroscopy. The
JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 100, NO. 3, MARCH 2011 DOI 10.1002/jps
POLYMORPHS AND HYDRATES OF ACYCLOVIR 951
sample was observed under polarized light with a Le-
ica DMLP microscope. Initially, samples were heated
from 30◦C to 250◦C at a rate of 5◦C/min. The trans-
formation product was then identified using Raman
spectroscopy and/or PXRD. The hotstage was cali-
brated using a caffeine standard.
Differential Scanning Calorimetry
Differential scanning calorimetry was performed on a
TA Instruments DSC Q10 calorimeter. Samples were
placed in hermetic aluminum pans and sealed using
a TA crimper. The temperature range was 25◦C to
300◦C, with a heating rate of 10◦C/min. The calorime-
ter was calibrated using an indium standard.
Thermogravimetric Analysis
Thermogravimetric analysis was performed on a TA
Instruments Q50 TGA thermogravimetric analyzer.
Samples were heated at a rate of 20◦C/min from room
temperature to 600◦C. Calibration of the instrument
was performed using nickel and alumel standards.
Solid-State 13C Nuclear Magnetic Resonance
13C solid-state NMR spectra of forms I and II were
obtained on a Varian VNMR J 600 MHz NMR sys-
tem equipped with a 4-mm double-resonance magic
angle spinning (MAS) probe using a Ramp-CP cross-
polarization technique.10 Other experimental param-
eters include contact time of 2-ms CP time, recycle de-
lay of 3 s, spinning speed of 18 kHz, and 80-kHz TPPM
(two-phase pulse modulation) proton-decoupling dur-
ing acquisition.11
Calculations of 13C chemical shifts were carried
out using the gauge-including atomic orbitals (GIAO)
method in the Gaussian03 program and the B3LYP
hybrid functional.12 Several basis sets ranging from
6-31G to 6-311++G (2d,p) were used to determine
the effect of the basis set size on predicted chemical
shift. Geometries for calculations were obtained by
optimizing hydrogen atoms positions determined by
crystallography (B3LYP /6-31G∗) while freezing the
heavy atom positions.13
RESULTS AND DISCUSSION
The relationships among the forms of ACV are dis-
cussed in the following text in the context of each
of the analytical method employed. Figure 2 summa-
rizes the conditions under which transformations oc-
cur between forms.
Raman Spectroscopy
Raman spectroscopy is a reliable way to differenti-
ate among ACV forms. The most distinctive region
is between 600 and 700 cm−1. In this region, form I
has two peaks at 641.5 and 670.4 cm−1 with a small
peak at 688.5 cm−1, whereas form II has four peaks
in the region at 632.5, 638.2, 666.2, and 686.8 cm−1
with a small peak at 700.8 cm−1. Form III has three
peaks at 639.3, 658.9, and 672.8 cm−1. The new hy-
drate, form VI, has three peaks at 640.1, 659.7, and
685.1 cm−1, whereas form V, the commercially avail-
able hydrate, has five peaks at 634.1, 644.0, 658.0,
681.9, and 698.4 cm−1. In the carbonyl and C N re-
gion, the forms also differ, probably due in part to dif-
ferences in the hydrogen bonding motifs. Form I has
peaks at 1606.3, 1628.5, and 1675.5 cm−1, whereas
form II has peaks at 1645.8 and 1702.7 cm−1. Form III
has peaks at 1614.2, 1630.6, 1672.3, and 1692.0 cm−1.
The hydrates also differ in this region with form VI
having peaks at 1625.7, 1631.4, and 1701.8 cm−1 and
form V also having three peaks at 1614.5, 1631.8, and
1695.3 cm−1. Other distinctive regions in the spectra
are between 100–200 and 1500–1600 cm−1. The Ra-
man spectrum of the high-temperature modification,
form IV, was found to be very similar to that of form I
with the exception of the peak at 1482 cm−1, which is
shifted discontinuously at the phase transition tem-
perature to 1480 cm−1. The Raman spectra are shown
in Figure 3. (Table 1 contains a listing of peaks.)
Variable temperature Raman spectroscopy shows
the progression of transformations occurring during
the heating of the hydrate form V (Fig. 4). The plot
shows a transition from form V to form III, to form I,
and then to form IV. Dehydration is observed around
90◦C as the peak at 672 cm−1 appears and other peaks
Figure 2. Schematic representation of observed acyclovir transformations.
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Figure 3. Raman spectra of the five forms of acyclovir (all spectra were taken at room tem-
perature except form III, which was taken at 90◦C).
in the spectrum begin to shift. Form III is observed
briefly before the transformation to form I. At ap-
proximately 180◦C, there is another shift observed at
1480 cm−1 that is associated with the transition to
the high-temperature modification (form IV). Upon
cooling to room temperature, form I is observed once
again. Figure 5 shows the same transition to the high-
temperature modification occurring during the heat-
ing of anhydrous form I.
Infrared Spectroscopy
Infrared spectroscopy probes differences in the influ-
ence of solid-state form on the molecular level arising
from changes in intramolecular and intermolecular
interactions.14,15 Form I, II, and V were sufficiently
stable and available in sufficient quantity to allow
study by FTIR spectroscopy (Table 2). The main re-
gion of difference among the forms is from 1600 to
1200 cm−1 (Fig. 6). Forms I and II have very similar
FTIR spectra, although the spectra differ mainly in
the region around 1700 to 1450 cm−1 in which some
of the common peaks are shifted to higher or lower
wavenumber. These changes can likely be ascribed to
alterations of C C, carbonyl, and C N stretching fre-
quencies. Another region in which forms I and II have
spectral differences is 1300 to 1000 cm−1. In this re-
gion, C−O vibrations are often located. These same
changes were observed in Raman spectroscopy. Other
peaks were shifted in the fingerprint (1000–600 cm−1)
region, which can be difficult to assign to specific vi-
brations by FTIR; nevertheless, Raman spectroscopy
is a better technique to analyze differences in this re-
gion. Taken together, these data suggest that forms I
and II have some changes in the conformation in the
ethoxy chain and the carbonyl region.
From 3600 to 3200 cm−1, theN−Hvibration region,
forms I and II have very similar spectra (Fig. 6). How-
ever, form V has a peak at 3470 cm−1 that is not ob-
served in forms I and II. In form V, the carbonyl peak
(1750–1640 cm−1) is not well observed compared with
forms I and II. The hydrate formV displays some peak
shifting in the N−H and C O regions of the spectra.
Because form V is a hydrate, the water molecules in
the structure can form more and stronger hydrogen
bonds, which lead to shifts of the carbonyl peak to
lower wavenumber than in forms I and II. The same
pattern was observed by Raman spectroscopy, with
some peaks shifted to around 1690 cm−1.
X-ray Diffraction
Powder X-ray diffraction allows reliable differentia-
tion among all ACV forms. Forms I, II, V, and VI were
analyzed using PXRD at room temperature, whereas
powder patterns of forms III and IV were obtained
at high temperature because of the instability of the
materials. Distinctive reflections in the powder pat-
terns of the forms include reflections between 2◦ and
10◦ 2θ among others. Table 3 lists the reflections ob-
served for all the forms of ACV and Figure 7 shows
the powder patterns.
Variable temperature PXRD was also performed
on forms I and V. The VT-PXRD of form I (Fig. 8)
shows that a high temperature modification appears
between 167◦C and 170◦C. This change corresponds
to an endothermic transition observed in DSC (vide
infra) and can be associated with a solid–solid transi-
tion. VT-PXRD of form V (Fig. 9) shows a total of two
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Table 1. Summary of Raman Peak Positions for the Five Forms of Acyclovir
Raman
Shift (cm−1) Form I Form II Form III Form V Form VI
100–200 Three peaks at 159.5,
176.8, and 190.8
Three peaks at 106.0,
162.8, and 185.9
Three peaks at 135.9,
171.1, and 194.8
Two peaks at 179.3
and 193.3
Three peaks at 141.6,
168.6, and 193.2
200–300 Three peaks at 222.15,
255.9, and 283.1
Five peaks at 209.0,
228.7, 258.4, 279.8,
and 291.4
Four peaks at 224.3,
255.4, 279.9, and
297.9
Three peaks at 223.0,
254.3, and 296.3
Two peaks at 208.7
and 234.7
300–400 Three peaks at 340.0,
348.2, and 380.3
Four peaks at 334.2,
350.7, 359.7, and
374.57
Five peaks at 320.0,
356.1, 370.0, 388.0,
and 398.6
Four peaks at 317.7,
358.1, 369.6, and
397.6
Three peaks at 323.3,
352.8, and 375.7
400–500 Two peaks at 400.9 and
441.3
Two peaks at 400.9
and 425.7
Two peaks at 442.0
and 452.7
One peak at 450.4 Four peaks at 400.3,
431.4, 457.6, and
494.4
500–600 Three peaks at 503.1,
534.4, and 577.3
Five peaks at 500.6,
527.0, 536.9, 571.5,
and 588.8
Three peaks at 505.9,
535.3, and 578.7
Three peaks at 508.9,
532.8, and 578.1
Four peaks at 507.5,
531.2, 548.4, and
582.0
600–700 Three peaks at 641.5,
670.4, and 688.5
Four peaks at 632.5,
638.2, 666.2, and
686.8
Three peaks at 639.3,
658.9, and 672.8
Five peaks at 634.1,
644.0, 658.0, 681.9,
and 698.4
Three peaks at 640.1,
659.7, and 685.1
700–800 Three peaks at 705.0,
751.9, and 789.0
Five peaks at 700.8,
740.4, 748.6, 770.0,
and 782.4
Three peaks at 702.3,
749.0, and 789.1
Three peaks at 756.0,
778.3, and 787.3
Three peaks at 701.5,
753.1, and 789.9
800–900 Three peaks at 819.5,
864.8, and 896.9
Four peaks at 820.3,
836.8, 874.7, and
884.6
Five peaks at 812.8,
826.7, 841.5, 867.7,
and 896.3
Four peaks at 827.7,
840.9, 871.4, and
896.1
Three peaks at 840.6,
869.3, and 894.7
900–1000 Two peaks at 932.3 and
983.4
One peak at 990.8 Two peaks at 975.7
and 984.7
One peak at 979.3 One peak at 907.0
1000–1100 Four peaks at 1015.6,
1025.44, 1071.6, and
1092.2
Three peaks at 1036.2,
1052.6, and 1080.6
Two peaks at 1028.1
and 1073.1
Six peaks at 1008.1,
1015.6, 1030.4,
1049.3, 1055.1, and
1078.2
Six peaks at 1001.9,
1016.6, 1031.4,
1051.0, 1078.0, and
1091.1
1100–1200 Two peaks at 1109.5 and
1182.8
Three peaks at 1118.5,
1182.8, and 1187.8
Two peaks at 1104.2
and 1184.5
Two peaks at 1108.7
and 1182.8
Two peaks at 1124.7
and 1185.3
1200–1300 Two peaks at 1221.5 and
1249.5
Two peaks at 1219.9,
1228.9, and 1252.8
Four peaks at 1222.1,
1246.7, 1288.4, and
1298.2
Four peaks at 1221.5,
1232.2, 1247.1,
1257.0, and 1288.3
Four peaks at 1226.2,
1250.0, 1283.5, and
1288.4
1300–1400 Five peaks at 1300.6,
1314.6, 1343.5, 1361.6,
1376.4, and 1397.8
Four peaks at 1303.1,
1316.3, 1356.7, and
1367.4
Three peaks at 1310.5,
1361.26, and 1391.5
Three peaks at 1313.0,
1359.1, and 1394.6
Four peaks at 1312.14,
1344.1, 1351.4, and
1364.5
1400–1500 Five peaks at 1411.0,
1425.9, 1450.6, and
1482.7
Four peaks at 1410.2,
1429.2, 1455.5, and
1486.8
Four peaks at 1405.5,
1421.8, 1447.2, and
1480.8
Five peaks at 1408.6,
1428.3, 1448.9,
1458.8, and 1486.0
Five peaks at 1415.3,
1426.0, 1457.0,
1473.4, and 1482.4
1500–1600 Two peaks at 1540.4 and
1575.8
Three peaks at 1545.3,
1574.8, and 1588.2
Two peaks at 1542.2
ad 1574.9
Two peaks at 1549.4
and 1578.3
Two peaks at 1548.7
and 1578.1
1600–1700 Three peaks at 1606.3,
1628.5, and 1675.5
Three peaks at 1604.6,
1645.8 and 1702.7
Four peaks at 1614.2,
1630.6, 1672.3, and
1692.0
Three peaks at 1614.5,
1631.8, and 1695.3
Three peaks at 1625.7,
1631.4, and 1701.8
transitions upon heating. Form V first dehydrates to
produce form III between 65◦C and 80◦C. Form III
then transforms to form IV between 170◦C and 180◦C.
This transition directly correlates to the endotherms
observed in the DSC of form V (vide infra). Once the
sample was cooled, it had transformed back to form I.
Thermomicroscopy, DSC, and TGA
Thermal studies were performed on ACV using DSC,
TGA, and thermomicroscopy. Thermomicroscopy was
also combined with Raman spectroscopy to provide
additional information about the changes occurring
as a function of temperature. TGA showed that forms
I and II were anhydrous. Form VI showed a weight
loss of 2.9%, whereas form V, the commercial hydrate,
showed a weight loss of 5.0%, which is expected of the
3:2 hydrate.
Differential scanning calorimetry was performed
on forms I, II, V, and VI (Fig. 10). Form I showed an
endothermic transition between 167◦C and 176◦C and
a melt/decomposition centered at 248.8◦C with an on-
set of 245◦C. Form II exhibited no transitions prior
to a melt/decomposition event centered at 260.1◦C
(onset of 257.6◦C). Form V showed two overlapping
transitions between 148◦C and 179◦C. Form VI exhib-
ited a loss of water between 50◦C and 90◦C, a transi-
tion at 170◦C, followed by the melt/decomposition at
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Figure 4. Variable temperature Raman spectroscopy plot starting with form V and showing
the Raman shifts during several phase transitions.
Figure 5. Variable temperature Raman spectroscopy plot starting with form I showing a
single-phase transition to form IV.
Figure 6. FTIR spectra for forms I, II, and V of acyclovir.
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Table 2. Summary of Peak Positions of the FTIR Spectra of Form I, II, and V of Acyclovir
Spectral Range (cm−1) Form I Form II Form V
3600–3200 Two peaks at 3432 and 3394 Two peaks at 3433 and 3389 Two peaks at 3470 and 3439
3200–2800 Three peaks at 3182 (broad), 3090,
and 2970
Three peaks at 3182 (broad), 3090,
and 2970
Single peak at 3182 (broad)
2000–1600 Four peaks at 1737, 1691, 1629
(sharp), and 1600
Five peaks at 1737, 1702, 1686,
1630, and 1600 (sharp)
Three peaks at 1709 (broad), 1631
(sharp), and 1611
1600–1400 Two peaks at 1538 and 1478
(sharp)
Three peaks at 1540, 1492, and
1479
Two peaks at 1542 and 1484
(sharp)
1400–1200 Four peaks at 1388, 1339, 1226,
and 1218
Four peaks at 1365 (broad), 1354,
1227, and 1217
Four peaks at 1389, 1345, 1309,
and 1215
1200–1000 Five peaks at 1186, 1106, 1090,
1065, and 1016
Six peaks at 1181, 1109, 1091,
1065, 1051, and 1016
Five peaks at 1182, 1104, 1048,
1032, and 1012
1000–800 Four peaks at 985, 920 (broad),
868 (sharp), and 822
Five peaks at 985, 923, 868
(sharp), 835, and 823
Two peaks at 902 and 892
800–600 Three peaks at 783, 752 (sharp),
and 680 (sharp)
Four peaks at 782, 770, 749
(sharp), and 682 (sharp)
Four peaks at 780 (sharp), 758,
749, and 682 (sharp)
252.9◦C (onset of 250.0◦C). Form V showed two over-
lapping transitions between 148◦C and 179◦C and a
melt/decomposition of 247.4 (onset of 240.0). When a
sample of form I was cycled between 40◦C and 190◦C
repetitively, the same transition was observed during
each heating cycle, showing that the transformation
is reversible. The DSC thermograms are shown in
Figure 10 and the associated data are in Table 4.
Single Crystal X-ray Diffraction
The previously unknown structure of form I was
solved from a single crystal grown from a methanol
solution in the presence of Nylon 6. In form I, as in
all forms of ACV, the guanine ring is planar (Fig. 11)
Table 5. The chain extends above the plane of the
guanine ring such that it is in the gauche conforma-
tion. The glycosidic torsion angle is 74.3◦. Because
of the quantity of hydrogen bond donors and accep-
tors present in ACV, the hydrogen bonding scheme is
extensive (Fig. 12). The amine of the guanine is hy-
drogen bonded to the hydroxyl of one molecule at a
distance (N···O) of 3.05 Å and the carbonyl of another
molecule at a distance (N···O) of 2.92 Å. The hydrogen
of the hydroxyl functionality also donates to the car-
bonyl. The remaining hydrogen bond is between the
secondary nitrogen of the five-membered ring and the
N−H of the six-membered ring at a distance (N···N)
of 2.82 Å. In total, each ACV molecule participates in
Figure 7. Powder X-ray diffraction patterns of all the forms of acyclovir.
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Table 3. Table of Reflections and Intensities for All the Forms of Acyclovir
Form I Form II Form III Form IV Form V Form VI
2θ (◦) Intensity (%) 2θ (◦) Intensity (%) 2θ (◦) Intensity (%) 2θ (◦) Intensity (%) 2θ (◦) Intensity (%) 2θ (◦) Intensity (%)
8.52 21.5 6.23 88.8 8.05 85.5 8.54 53.9 6.99 72.8 5.9 100
11.66 35.6 8.48 6.5 11.35 55.4 11.54 45.1 8.56 8 7.75 6.7
14 6.3 12.14 66.2 12.45 1.8 13.7 23.5 9.26 0.8 9.15 33.7
14.56 0.5 13.55 19.9 13.55 1.5 15.56 6.1 10.5 65.1 10.4 26.3
15.85 11.2 16.56 19.3 14.64 5.5 19.22 63.5 11.34 0.6 13.4 20.2
17.5 1.5 16.99 21.3 16 20.9 20.94 9.2 13.06 8.7 15.19 6.4
18.26 8 18.71 54.2 17.6 21.9 22.54 93.9 16.06 15 15.6 4.6
18.89 21.9 19.72 54.9 18.15 38 23.96 25.3 18.25 7 16.5 3.9
19.72 29.4 20.62 16 18.5 32.3 24.96 16.3 19.1 4.5 17.4 3.8
22.04 2.5 21.43 8.9 19.54 1.2 26.12 15.7 20.13 7.2 18.45 5.2
23.4 55.9 22.48 19.3 20.09 3.9 27.03 100 21.05 5 19.7 2.5
24.07 60.5 23.05 24 21.24 7.4 27.76 2 21.9 4.9 20.25 2.9
25.39 26.7 23.88 100 21.65 3 28.7 8.6 23.42 11.3 20.95 10
27.2 7 24.5 5 22.7 69.1 30.18 16.1 23.92 51.7 22.31 12.2
28.74 100 24.91 7.6 23.25 62 31.18 6.7 26.14 100 23.55 45
30.43 8.9 25.67 83.3 24.5 18.9 31.54 7.2 27.39 6.4 25.95 42.1
31.66 3.9 26.76 8.5 25.45 19.8 32.76 1.9 29.26 48.2 27.2 68
33.17 6.3 26.95 10.4 26.66 2 33.32 16.8 31 5.4 28.85 3.8
34.2 10.3 27.69 64.2 27.7 100 33.76 7.5 32.33 3.2 29.8 15.6
35.48 3.1 29.35 6.3 29.35 8.1 34.91 2.9 32.79 1.6 31.45 5.4
36.53 9.1 29.89 32.5 30.57 1.6 39.98 5.2 33.57 5.2 32.25 2.4
40.09 1.9 31.19 9.2 31.74 1.7 34.45 4.5 32.8 2.9
41.22 4.7 31.5 8.3 33.11 2.6 35.78 2.6 33.25 2.7
42.59 2.5 32.35 2.2 33.7 10.6 36.99 2.8 34.65 1.6
43.72 3.2 33.3 16.9 34.61 2.6 38.32 4 35.35 4.5
45.65 1.6 34.35 7.3 35.7 3.5 38.89 3.1 36.05 2.4
47.89 1.7 34.75 5.9 36.51 1.5 39.97 1.9 37.26 5.8
49.05 2.2 36.35 23.3 39.09 3.4 40.73 3.4 39.2 2.7
37.94 2.6 40.78 1.1 42.51 1.3 39.75 5.9
38.94 6.1 41.5 2 43.69 3.6 41.5 5.4
39.8 7.6 42.75 1.5 44.38 1 42.85 4
42.1 5.1 43.96 1.4 45.22 1.2 46.45 1.9
43.96 2.7 46.36 0.7 47.37 1.2 47.3 2
45.8 3.1 46.97 0.9 48.49 1.6 48.15 2
46.75 4.7 47.49 1 48.87 2 49.66 0.8
47.75 3.6 48.39 1.5 49.64 1.3
48.6 2.2 48.72 1
49.21 3.8
Table 4. Differential Scanning Calorimetry Data for Forms I,
II, V, and VI of Acyclovir
Form I Form II Form V Form VI
Melt (◦C) 248.8 260.1 247.4 252.9
Transition (◦C) 165–175 – 150–175 54–70
Transition 2 (◦C) – – 175–190 70–100
Transition 3 (◦C) – – – 165–175
Melt/decomposition
(kcal/mol)
8.48 8.24 8.81 6.84
Transition (kcal/mol) 0.57 – 0.44 1.93
Transition 2 (kcal/mol) – – 0.06 4.66
Transition 3(kcal/mol) – – – 0.44
eight hydrogen bonds. The ether and aryl nitrogen do
not participate in the hydrogen bonding network. The
molecules pack in sheets along the b-axis. Along the
c-axis, the molecules pack in columns such that they
alternate the orientation of the guanine ring.
Although a crystal of form II that was of suitable
size and quality for single crystal X-ray diffraction
was not obtained, a unit cell was determined for a
dozen small crystals. The unit cell dimensions are as
follows: a = 4.75 Å, b = 15.12 Å, c = 28.68 Å, and
β = 91.16◦. Further experimental or theoretical stud-
ies will be needed to elucidate the molecular packing
pattern and its relation to the other structurally char-
acterized polymorph of ACV.
Acyclovir form VI is a 1:2 ACV/H2O hydrate with a
triclinic unit cell of a = 6.8004(5) Å, b = 11.3317(9) Å,
c = 14.9368(12) Å, α = 82.722(1)◦, β = 82.502(1)◦,
and γ = 89.323(1)◦. The side chain of both ACV
molecules in the unit cell is in the gauche conforma-
tion, whereas the guanine rings are approximately
planar. The glycosidic torsion angles are 92.7◦ and
89.7◦. Water molecules are in two channels that run
parallel to the a-axis. The hydrogen bonding network,
such as that of form I, is extensive. In addition to
JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 100, NO. 3, MARCH 2011 DOI 10.1002/jps
POLYMORPHS AND HYDRATES OF ACYCLOVIR 957
Figure 8. Variable temperature PXRD starting from form I of acyclovir.
hydrogen bonding between ACV molecules, the water
molecules are bound not only to each other but also
to the ACV molecules surrounding them. The ACV
molecules stack such that the chains are orientated
toward the water channels and the guanine rings al-
ternate their orientation (Fig. 13).
Form V has two water molecules for every three
ACVmolecules in the asymmetric unit. The asymmet-
ric unit contains three different ACV molecules. In
eachmolecule, the guanine ring is planar whereas the
conformation of the chain varies. In the first residue,
the chain is extended almost perpendicular to the
plane of the guanine. Its glycosidic torsion angle is
97.2◦. Like form I, the chain is in a gauche confor-
mation. The second residue is much like the first,
with a glycosidic torsion angle of 104.3◦. In the third
residue, the chain is fully extended and in the trans
conformation. Its glycosidic torsion angle is 91.4◦.6
One water molecule hydrogen bonds to two different
molecules of residue 3, one through the carbonyl func-
tionality and the other through the hydroxyl group, in
addition to bonding to the hydroxyl group of residue
1. The other water molecule is hydrogen bonded to
one molecule of each of the residues; residue 1 hy-
drogen bonds through the carbonyl, whereas residue
2 hydrogen bonds through a hydroxyl group and
Figure 9. Variable temperature PXRD starting from form V of acyclovir.
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Figure 10. Differential scanning calorimetry thermograms of forms I, II, V, and VI of acyclovir.
residue 3 hydrogen bonds through the amine. The
residues themselves form dimers, with residue 1
forming a homodimer and residue 2 dimerizing with
residue 3, creating infinite sheets within the crystal
structure (Fig. 14).6
Solid-State Nuclear Magnetic Resonance
Generally, themost definitive analytical data for poly-
morph identification is single crystal X-ray diffrac-
tion, although for many samples such data are
not available. In such cases, solid-state NMR spec-
troscopy (SS-NMR) can be used to identify the exis-
tence of polymorphs and provides detailed informa-
tion concerning hydrogen bonding interactions.16,17
Here, SS-NMR was used to further analyze form
II because there was no crystallographic informa-
tion for this form. SS-NMR is sensitive to conforma-
tional changes and alterations in intermolecular in-
teractions as evidenced by the chemical shifts of the
atoms directly involved in the interactions. SS-NMR
data were collected at room temperature for forms
I, II, and V, revealing significant differences among
the forms (Fig. 15). The preliminary assignment of
isotropic chemical shifts for ACV forms I and V was
made by comparison to computed values (Fig. 1 and
Table 6).12,13 In the low-frequency region, form I has a
singlet at 56 ppm whereas form V appears at 61 ppm.
Moreover, form II has two peaks detected at 59 and
62 ppm. This low-frequency region is assigned to the
ethoxy chain of ACV molecule. There is a 5 ppm up-
field shift of C8 resonance from form V compared with
form I and 3 ppm compared with form II. This chemi-
cal shift differencemay be attributed to gauche versus
Figure 11. Packing of form I acyclovir viewed along the (a) b-axis and (b) c-axis.
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Figure 12. Hydrogen bonding interactions present in form I of acyclovir.
trans conformations. In the crystal structure of form
I, the chain has adopted a gauche conformation. For
form V, two of three different ACV molecules have
gauche conformation.
In the high-frequency region, a signal at 166 ppm
is observed for forms I and II corresponding to the
carbonyl carbon (C2). An upfield shift of this peak (to
159 ppm) is observed for form V. This 7-ppm shift can
be attributed to the formation of a hydrogen bond to
the carbonyl group.18 Moreover, because form V is a
hydrate and forms I and II are not hydrates, this is
consistent with expectations from the crystal struc-
ture of form V, which has extensive hydrogen bonding
compared with form I. The same hydrogen bonding
observations and shifts were found from Raman and
infrared spectroscopy analyses performed on these
forms.
Theoretical NMR calculations of 13C isotropic
chemical shifts (Fig. 1 and Table 6) and computed
spectra (not shown) reveal very similar shifts com-
pared with the experimental data. However, C8, the
carbon at the terminal of the ethoxy chain, in form V
shifts upfield in the experimental data compared with
calculations.
Variable Temperature
Further analyses were performed on form V to con-
firm the existence and the distinctive conversion to
form IV at 180◦C by variable temperature 13C SS-
NMR experiments (Fig. 16). Form V was heated from
30◦C to 150◦C during MAS inside the probe and no
changes were observed in the spectra. However, some
differences in the spectra were observed when the
temperature of the sample was increased to 180◦C
consistent with a phase transition to form IV. Peaks
observed at 74 and 71 ppm at a low temperature
(30◦C) were observed as a single peak at 74 ppmwhen
the temperature was increased to 180◦C. This can be
attributed to rotational/inversion processes that con-
tribute to the site-exchange effect forming a single
peak at 180◦C.16,19,20 This process would require the
breaking and formation of hydrogen bonds due to the
dehydration process. Furthermore, peaks observed at
Figure 13. Packing diagram of the 1:2 acyclovir/H2O down the (a) a-axis and (b) b-axis.
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Table 5. Structural Data of Forms I, V, and VI of Acyclovir and the Hypothetical Unit Cell of Form II
Form I Form II Form V6 Form VI
Crystal System monoclinic monoclinic monoclinic triclinic
Space Group P21/c P21/n P1¯
Unit Cell
a = 10.9121(11) Å 4.75 25.459(1) 6.8004(5)
b = 11.1311(12) Å 15.12 11.282(1) 11.3317(9)
c = 7.8843(8) Å 28.68 10.768(1) 14.9368(12)
" = 90.00◦ 90.00◦ 90.00◦ 82.722(1)
$ = 108.262(2)◦ 91.16◦ 95.16(1) 82.502(1)
( = 90.00◦ 90.00◦ 90.00◦ 89.323(1)
Volume 909.422 3080.34 1131.98
Z 4 12 4
Density 1.645 g/cm3 1.63 g/cm3 1.533 g/cm3
Crystal Size 0.11 × 0.03 × 0.01 0.550 × 0.125 × 0.025 0.22 × 0.10 × 0.02
Goodness of Fit 1.051 1.031
Final R indices (obs data)
[I> 2F(I)]
0.0427 0.0365
Final R indices (all data) 0.0652 0.0523
wR 0.0886 0.0857
Figure 14. Packing diagram of the commercial hydrate viewed along the (a) b-axis and (b)
c-axis.
Figure 15. Cross-polarization magic angle spinning 13C NMR spectra of forms I, II, and V of
acyclovir at ambient temperature.
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Figure 16. Variable temperature cross-polarization magic angle spinning 13C NMR spectra
of acyclovir form V heated from 30◦C to 180◦C.
Table 6. 13C Chemical Shifts (ppm) Using the GIAO Method
and B3LYP Hybrid Functional and 6-311++G (2d,p) Basis Set for
Acyclovir Forms I and V
13C Chemical Shift (ppm)
C1 C2 C3 C4 C5 C6 C7 C8
Form I 155.3 161.0 123.6 154.2 141.4 69.4 71.7 62.6
Form V 153.1 161.3 125.1 154.3 140.1 76.1 75.3 66.5
153.1 161.0 127.1 149.9 140.8 78.3 71.9 65.3
156.7 158.5 126.3 154.7 137.8 76.1 73.1 62.4
62 and 139 ppm at a low temperature were observed
as two peaks at 63 and 60 ppm and 141 and 137 ppm,
respectively, at 180◦C. From the observed chemical
shifts and intensities of the peaks, it can be concluded
that form V undergoes a phase transition at 180◦C to
form IV. 13C chemical shifts are strongly influenced by
torsion angles of molecules and at high temperatures
the molecules have more mobility than at low temper-
ature. This observation is consistent with the variable
temperature Raman data (Fig. 4), in which a change
in 1480 cm−1 can be correlated to -CH2 bending lo-
cated in the ethoxy chain of ACV. Moreover, at this
temperature, the form V is dehydrated apparently to
a phase with more motion. When the sample is cooled
from 180◦C to 30◦C, no major changes were observed
in the SS-NMR spectra consistent with the inability of
the material to rehydrate or further transform under
these conditions (Fig. 17).
CONCLUSION
Using a range of techniques, we have conclusively
shown that ACV has several forms ranging from
hydrates to anhydrates. Raman spectra and PXRD
patterns are reported for all six forms. The crystal
structures of the anhydrous form I and both hydrate
forms (form V and form VI) have been determined. Al-
though the unit cell of the anhydrous form II was de-
termined, the crystal structure remains elusive. The
existence under nonambient conditions of forms III
and IV was also shown through PXRD. The anhy-
drate form IV was found using variable temperature
analysis as a transformation from commercial hy-
drate form V for the first time. Solid-state NMR pro-
vided direct chemical information on the forms and
allowed following the phase transformation in situ.
However, the precise mechanism of the phase trans-
formation in terms of the dehydration process has not
yet been elucidated. Significant differences in inter-
molecular hydrogen bonding networks were observed
among the ACV forms and are consistent with the
solid-state NMR and vibrational spectroscopy analy-
sis exhibiting distinct chemical shifts and vibrational
frequencies.
DOI 10.1002/jps JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 100, NO. 3, MARCH 2011
962 LUTKER ET AL.
Figure 17. Variable temperature cross-polarization magic angle spinning 13C NMR spectra
of acyclovir form V upon cooling.
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